(Q35912691)

11 August 2017

Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears (English)

1 reference

11 August 2017

0 references

0 references

1 reference

pulmonary tuberculosis

1 reference

Diacon AH

1

1 reference

11 August 2017

Patientia RF

2

1 reference

11 August 2017

Venter A

3

1 reference

11 August 2017

van Helden PD

4

1 reference

11 August 2017

Smith PJ

5

1 reference

11 August 2017

McIlleron H

6

1 reference

11 August 2017

Maritz JS

7

1 reference

11 August 2017

Donald PR

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

21 May 2007

1 reference

Antimicrobial Agents and Chemotherapy

11 August 2017

1 reference

11 August 2017

51

1 reference

11 August 2017

8

1 reference

11 August 2017

2994-2996

1 reference

An official ATS statement: hepatotoxicity of antituberculosis therapy

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Therapeutic drug monitoring in the treatment of tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Low plasma concentrations of rifampicin in tuberculosis patients in Indonesia.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Role of individual drugs in the chemotherapy of tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Adverse Effects of Rifampin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Pharmacokinetics and Metabolism of Rifampin in Humans

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Jaundice during treatment with rifampicin (12 cases)

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Treatment of chronic drug-resistant pulmonary tuberculosis with rifampin and ethambutol

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

U.S. Public Health Service Cooperative trial of three rifampin-isoniazid regimens in treatment of pulmonary tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

The early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

A multicentre study of the early bactericidal activity of anti-tuberculosis drugs

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932511

What is the 'right' dose of rifampin?

24 September 2018

1 reference

12 December 2020

Jaundice after rifampicin

1 reference

12 December 2020

Two three-month treatment regimens for pulmonary tuberculosis

1 reference

12 December 2020

The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis

1 reference

12 December 2020

[Antibiotic treatment of brucellosis]

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.01474-06

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

17517849

1 reference